Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis

INTRODUCTION: Moderate hypofractionated (HF) radiotherapy is becoming the new standard in radiotherapy for prostate cancer patients. It is established as safe, but it might be associated with increased acute toxicity levels. We conducted a systematic review on moderate HF to establish acute toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinzabakira, F., Brand, V., Heemsbergen, W.D., Incrocci, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040508/
https://www.ncbi.nlm.nih.gov/pubmed/36992969
http://dx.doi.org/10.1016/j.ctro.2023.100612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040508/
https://www.ncbi.nlm.nih.gov/pubmed/36992969
http://dx.doi.org/10.1016/j.ctro.2023.100612

Ejemplares similares